Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
01/07/1999 | EP0888386A1 Stable factor viii/ von willebrand factor complex |
01/07/1999 | EP0888385A2 Uses of gdnf and gdnf receptor |
01/07/1999 | EP0888381A1 Targeted therapeutic or diagnostic agents and methods of making and using same |
01/07/1999 | EP0888379A1 Compounds related to the amidinium family, pharmaceutical compositions containing same, and uses thereof |
01/07/1999 | EP0888377A1 MURINE $g(a)(1,3)FUCOSYLTRANSFERASE Fuc-TVII, DNA ENCODING THE SAME, METHOD FOR PREPARING THE SAME, ANTIBODIES RECOGNIZING THE SAME, IMMUNOASSAYS FOR DETECTING THE SAME, PLASMIDS CONTAINING SUCH DNA, AND CELLS CONTAINING SUCH A PLASMID |
01/07/1999 | EP0888376A1 Method for inhibiting tumor cell growth |
01/07/1999 | EP0888374A1 High affinity nucleic acid ligands of complement system proteins |
01/07/1999 | EP0888373A1 Smooth muscle cell lim protein |
01/07/1999 | EP0888368A1 Polyvalent polymers for the treatment of rotavirus infection |
01/07/1999 | EP0888363A1 Siloxane dyes, compositions containing same and uses thereof |
01/07/1999 | EP0888360A1 Penicillin glycolate |
01/07/1999 | EP0888358A1 Piperidine derivatives |
01/07/1999 | EP0888357A1 Azaspiro derivatives |
01/07/1999 | EP0888356A1 Condensed 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors |
01/07/1999 | EP0888355A1 Heterocyclic compounds and their preparation and use |
01/07/1999 | EP0888353A1 Novel n-7-heterocyclyl pyrrolo 2,3-d]pyridines and their use |
01/07/1999 | EP0888352A1 Fused imidazole derivatives as multidrug resistance modulators |
01/07/1999 | EP0888351A1 Pyrimido 5,4-d]pyrimidines, medicaments containing these compounds, their use and process for their production |
01/07/1999 | EP0888350A1 Azolobenzazepine derivatives as neurologically active agents |
01/07/1999 | EP0888349A1 Pyrrolopyrimidines and processes for their preparation |
01/07/1999 | EP0888347A1 Pharmaceutically useful compounds |
01/07/1999 | EP0888346A1 Coralyne analogs as topoisomerase inhibitors |
01/07/1999 | EP0888344A1 Spirocycle integrin inhibitors |
01/07/1999 | EP0888341A1 Novel sulphur derivatives comprising an amide bond, method for preparing same, use thereof as drugs, and pharmaceutical compositions containing such derivatives |
01/07/1999 | EP0888340A1 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists |
01/07/1999 | EP0888337A1 Piperidone tachykinin antagonists |
01/07/1999 | EP0888336A1 Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino)p iperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases |
01/07/1999 | EP0888335A1 Novel pyrimidine compounds useful in treating cytokine mediated diseases |
01/07/1999 | EP0888333A1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
01/07/1999 | EP0888330A1 Methods of treating or preventing interstitial cystitis |
01/07/1999 | EP0888329A1 NOVEL ASYMMETRIC SYNTHESIS OF R-$g(a)-PROPYL-PIPERONYL AMINE AND ITS ANALOGS |
01/07/1999 | EP0888327A1 Benzopyran derivatives having leukotriene-antagonistic action |
01/07/1999 | EP0888326A2 Novel ortho-naphthoquinone derivatives, novel synthesis therefor, and their use in the inhibition of neoplastic cell growth |
01/07/1999 | EP0888325A1 Novel cyclic amino acids as pharmaceutical agents |
01/07/1999 | EP0888324A1 2-aminoethyl-benzofuran derivatives, preparation thereof and therapeutical use thereof |
01/07/1999 | EP0888323A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
01/07/1999 | EP0888322A2 Electrophilic ketones for the treatment of herpesvirus infections |
01/07/1999 | EP0888320A1 Novel n-aminoalkyl-2-anthracenecarboxamides; new dopamine receptor subtype specific ligands |
01/07/1999 | EP0888319A1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
01/07/1999 | EP0888317A1 Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma |
01/07/1999 | EP0888316A1 2-(3h)-oxazolone derivatives and their use as cox-2 inhibitors |
01/07/1999 | EP0888313A1 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors |
01/07/1999 | EP0888310A1 Cinnoline derivatives and use as medicine |
01/07/1999 | EP0888309A1 Imidazole derivatives having affinity for alpha2 receptors activity |
01/07/1999 | EP0888307A1 1,3,5-trisubstituted indazole derivatives with an anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating action |
01/07/1999 | EP0888303A1 Synthetic derivatives of rapamycin as multimerizing agents for chimeric proteins with immunophilin-derived domains |
01/07/1999 | EP0888302A1 N- (r)-1- 3-(4-piperidyl)propionyl-3-piperidylcarbonyl]-2(s)-acetylamino-beta-alanine as fibrinogen receptor antagonist |
01/07/1999 | EP0888301A1 Mcbi analogs of cc-1065 and the duocarmycins |
01/07/1999 | EP0888299A1 Sulphur derivatives with a retroamide bond as endothelin-converting enzyme inhibitors |
01/07/1999 | EP0888298A2 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
01/07/1999 | EP0888293A1 N-acylaminoalkylhydrazinecarboximidamides |
01/07/1999 | EP0888292A1 TRICYCLIC COMPOUNDS HAVING ACTIVITY SPECIFIC FOR INTEGRINS, PARTICULARLY $g(a)v$g(b)3 INTEGRINS, METHOD FOR PREPARING SAME, INTERMEDIATES THEREFOR, USE OF SAID COMPOUNDS AS DRUGS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
01/07/1999 | EP0888290A1 Azulenyl nitrone spin trapping agents, methods of making and using same |
01/07/1999 | EP0888289A1 Anticonvulsant enantiomeric amino acid derivatives |
01/07/1999 | EP0888286A1 Novel substituted cyclic amino acids as pharmaceutical agents |
01/07/1999 | EP0888285A1 Novel bridged cyclic amino acids as pharmaceutical agents |
01/07/1999 | EP0888278A1 Antidiabetic agents |
01/07/1999 | EP0888276A1 Cinnamylidene camphor derivatives and their use as uv-a protecting agents |
01/07/1999 | EP0888271A1 Benzamidine derivatives substituted by amino acid and hydroxy acid derivatives and their use as anti-coagulants |
01/07/1999 | EP0888267A1 Novel pyruvate compounds and methods for use thereof |
01/07/1999 | EP0888138A1 Topical formulations for the treatment of nail psoriasis |
01/07/1999 | EP0888128A2 Delivery of exogenous compounds |
01/07/1999 | EP0888126A1 Anti-idiotypic antibody vaccines |
01/07/1999 | EP0888125A1 Glycosylated humanized b-cell specific antibodies |
01/07/1999 | EP0888124A1 Immunogenic compositions comprising porphyromonas gingivalis peptides and methods |
01/07/1999 | EP0888123A2 Antagonism of endothelin actions |
01/07/1999 | EP0888121A1 Use of vasopressin receptor antagonist for regulation of acth release |
01/07/1999 | EP0888118A1 Enhancement of microbial colonisation of the gastrointestinal tract |
01/07/1999 | EP0888117A1 Use of arabinogalactan in a sperm wash product |
01/07/1999 | EP0888116A1 Use of dehydroepiandrosterone for the treatment of addictions |
01/07/1999 | EP0888115A1 Iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
01/07/1999 | EP0888114A1 USE OF (+)-$g(a)-(2,3-DIMETHOXYPHENYL)-1- 2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL IN TREATING DEPRESSIVE DISORDERS AND BIPOLAR DISORDERS |
01/07/1999 | EP0888113A1 Use of an alkanoyl-l-carnitine for the treatment of glutamate mediated diseases |
01/07/1999 | EP0888112A1 New use of ammonium compounds and/or urea |
01/07/1999 | EP0888111A1 Modified release multiple-units dosage composition |
01/07/1999 | EP0888110A1 Composite gel microparticles as active principle carriers |
01/07/1999 | EP0888062A1 Antibacterially active marine algae extracts from the class diatomatae and methods of use |
01/07/1999 | EP0888054A1 Targeted site specific drug delivery compositions and method of use |
01/07/1999 | EP0888052A1 Xanthone analogs for the treatment of infectious diseases |
01/07/1999 | EP0888049A1 Novel antimicrobial activity of gemfibrozil |
01/07/1999 | EP0876818A4 Agent for treating neuro-degenerative disorders |
01/07/1999 | EP0871373A4 Aliphatic amide feed supplement for ruminants |
01/07/1999 | EP0866683A4 Composition and method for treating diseased nails |
01/07/1999 | EP0854713A4 Compositions of melatonin and analgetic agents and methods of use thereof |
01/07/1999 | EP0839520B1 Rinsing composition for the care of the skin |
01/07/1999 | EP0777463B1 Gelling compositions comprising optically enriched gellants |
01/07/1999 | EP0758340B1 Process for the preparation of 4-amino-delta 4-3-ketosteroids via 4-nitro-delta 4-3-ketosteroids |
01/07/1999 | EP0724592B1 16-substituted-4-aza-androstane 5-alpha-reductase isozyme 1 inhibitors |
01/07/1999 | EP0721334B1 Transdermal therapeutic system containing octyl dodecanol as crystallization inhibitor |
01/07/1999 | EP0712412B1 15,15-dialkyl-substituted derivatives of estradiol |
01/07/1999 | EP0639580B1 Glycosphingolipids |
01/07/1999 | EP0565674B1 Method for memory enhancement and quality of life improvement |
01/07/1999 | EP0397823B1 Contraception system and method |
01/07/1999 | EP0386117B1 Treating premenstrual or late luteal phase syndrome |
01/07/1999 | DE19829229A1 Hydrazinderivate Hydrazine |
01/07/1999 | DE19728517A1 TTS zur Verabreichung von Sexualsteroidhormonen TTS for the administration of sex steroids |
01/07/1999 | DE19728516A1 TTS zur Verabreichung von Levonorgestrel TTS for the administration of levonorgestrel |
01/07/1999 | DE19728436A1 Niedrigdosierte 15-Desoxyspergualin-Präparate Low-dose 15-deoxyspergualin preparations |
01/07/1999 | DE19728326A1 Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln New quinoxalinedione derivatives, their preparation and use in medicaments |
01/07/1999 | DE19728301A1 Verwendung von Inhibitoren der Phosphodiesterase 4 für die Behandlung der allergischen Rhinitis Use of inhibitors of phosphodiesterase 4 for the treatment of allergic rhinitis |